Meditation may ease anxiety and improve sleep for stem cell patients
NCT ID NCT07462962
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether mindfulness meditation training could help patients who are undergoing a stem cell transplant and staying in a sterile room. 70 adult patients participated, and the researchers measured their anxiety and sleep quality before and after the meditation practice. The goal was to see if this simple, safe technique could improve their emotional and physical well-being during a stressful hospital stay.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- mindfulness meditation training
- What this could lead to
- If it works, this could offer a safe, drug-free way to help stem cell transplant patients feel less anxious and sleep better during their hospital stay.
- What could go wrong
- This is a small, completed study with only 70 participants, so results may not apply to everyone. The benefits might be modest and need confirmation in larger trials.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
70 people
The number who actually took part.
- Started
-
Mar 2025
- Finished
-
Jun 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
(1) Patients with secondary transplantation, (2) Patients with other critical illness, such as malignancy, cardiac failure, renal failure, respiratory failure, severe traum, (3) patients with mental illness or psychotherapy before admission.
- Ages
-
Children (under 18), adults (18 to 64) and older adults (65 and over)
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age 18 years * HSCT * Volunteered to join the study Exclusion Criteria: * Patients with secondary transplantation * Patients with other critical illness, such as malignancy, cardiac failure, renal failure, respiratory failure, severe traum * Patients with mental illness or psychotherapy before admission
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cancer and / or hematological malignancy are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Henan University
Kaifeng, Henan, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can regional data improve bone marrow transplant results for blood cancers?
- Could a frailty score predict which older cancer patients survive intensive care?
- Why COVID-19 hits blood cancer patients harder: scientists map the immune clues
- Softer chemo before stem cell transplant aims to cure blood cancers in frail children
- Can toothbrushing and rinses stop painful mouth sores in child transplant patients?
- Can a new drug stop the Body's attack after stem cell transplants?